Skip to content
Toggle main navigation
Immunize Oregon logo
Immunize Oregon logo
  • Welcome
    • Immunize Oregon
  • Vaxx Clinic
  • Events
  • Groups
  • News
  • Opportunities
  • Lobby
    Log in
    Request to join
    Select an available language
    EN

    News

    All
    3-D printing
    Abdul Latif Jameel Poverty Action Lab (J-PAL)
    Abdul Latif Jameel Water and Food Systems Lab (J-WAFS)
    Administration
    Aeronautical and astronautical engineering
    Africa
    Agriculture
    Algorithms
    Alumni/ae
    Alzheimer's
    Anesthesia
    Anthropology
    Antibiotics
    Artificial intelligence
    Asia
    See all

    Highlighted News

    Results (29)

    MIT engineers create nanoparticles for delivering personalized cancer vaccines

    MIT engineers create nanoparticles for delivering personalized cancer vaccines

    A nanoscale particle with a unique structure, developed at MIT, holds potential as a customizable delivery vehicle for personalized cancer vaccines.The backbone of the vaccine is a modified, harmless bacteriophage called M13, which forms a nanofiber that can be coated with cancer antigens. By precisely controlling the density of those cancer proteins, the researchers found that they could create a
    October 30, 2026
    New formulation helps RNA vaccines withstand high temperatures

    New formulation helps RNA vaccines withstand high temperatures

    RNA vaccines, which have been proven effective against Covid-19, are now being developed for many other diseases, including cancer. One of the drawbacks to these vaccines is that they require ultracold storage, but researchers from MIT have found a promising way to overcome that limitation.With help from an AI algorithm, the researchers tweaked the formulation surrounding the lipid nanoparticles t
    September 28, 2026
    A new vaccine adjuvant could make it easier to eradicate polio

    A new vaccine adjuvant could make it easier to eradicate polio

    In the United States, children routinely receive an injectable form of the polio vaccine. This vaccine is very effective at preventing illness, but it doesn’t block transmission of the polio virus as well as the oral polio vaccine does.Poliovirus is usually transmitted through contaminated food or water, so the GI tract is where the body is first exposed. Because the oral vaccine induces a mucosal
    June 3, 2026
    A new approach to cancer vaccination yields more powerful T cells

    A new approach to cancer vaccination yields more powerful T cells

    MIT engineers have developed a new way to amplify the T-cell response to mRNA vaccines — an advance that could lead to much more powerful cancer vaccines and stronger protection against infectious diseases.Most vaccines generate both antibodies and T cells that can target the vaccine antigen by activating antigen-presenting cells, such as dendritic cells. In this study, the researchers boosted the
    May 13, 2026
    Particles that enhance mRNA delivery could reduce vaccine dosage and costs

    Particles that enhance mRNA delivery could reduce vaccine dosage and costs

    A new delivery particle developed at MIT could make mRNA vaccines more effective and potentially lower the cost per vaccine dose.In studies in mice, the researchers showed that an mRNA influenza vaccine delivered with their new lipid nanoparticle could generate the same immune response as mRNA delivered by nanoparticles made with FDA-approved materials, but at around 1/100 the dose.“One of the cha
    November 7, 2025
    Five with MIT ties elected to National Academy of Medicine for 2025

    Five with MIT ties elected to National Academy of Medicine for 2025

    On Oct. 20 during its annual meeting, the National Academy of Medicine announced the election of 100 new members, including MIT faculty members Dina Katabi and Facundo Batista, along with three additional MIT alumni.Election to the National Academy of Medicine (NAM) is considered one of the highest honors in the fields of health and medicine, recognizing individuals who have demonstrated outstandi
    October 22, 2025
    Supercharged vaccine could offer strong protection with just one dose

    Supercharged vaccine could offer strong protection with just one dose

    Researchers at MIT and the Scripps Research Institute have shown that they can generate a strong immune response to HIV with just one vaccine dose, by adding two powerful adjuvants — materials that help stimulate the immune system.In a study of mice, the researchers showed that this approach produced a much wider diversity of antibodies against an HIV antigen, compared to the vaccine given on its
    June 18, 2025
    Particles carrying multiple vaccine doses could reduce the need for follow-up shots

    Particles carrying multiple vaccine doses could reduce the need for follow-up shots

    Around the world, 20 percent of children are not fully immunized, leading to 1.5 million child deaths each year from diseases that are preventable by vaccination. About half of those underimmunized children received at least one vaccine dose but did not complete the vaccination series, while the rest received no vaccines at all.To make it easier for children to receive all of their vaccines, MIT r
    May 15, 2025
    Biologists identify targets for new pancreatic cancer treatments

    Biologists identify targets for new pancreatic cancer treatments

    Researchers from MIT and Dana-Farber Cancer Institute have discovered that a class of peptides expressed in pancreatic cancer cells could be a promising target for T-cell therapies and other approaches that attack pancreatic tumors.Known as cryptic peptides, these molecules are produced from sequences in the genome that were not thought to encode proteins. Such peptides can also be found in some h
    May 8, 2025
    A blueprint for better cancer immunotherapies

    A blueprint for better cancer immunotherapies

    Immune checkpoint blockade (ICB) therapies can be very effective against some cancers by helping the immune system recognize cancer cells that are masquerading as healthy cells. T cells are built to recognize specific pathogens or cancer cells, which they identify from the short fragments of proteins presented on their surface. These fragments are often referred to as antigens. Healthy cells will
    November 25, 2024
    A two-dose schedule could make HIV vaccines more effective

    A two-dose schedule could make HIV vaccines more effective

    One major reason why it has been difficult to develop an effective HIV vaccine is that the virus mutates very rapidly, allowing it to evade the antibody response generated by vaccines.Several years ago, MIT researchers showed that administering a series of escalating doses of an HIV vaccine over a two-week period could help overcome a part of that challenge by generating larger quantities of neutr
    September 20, 2024
    MIT scientists use a new type of nanoparticle to make vaccines more powerful

    MIT scientists use a new type of nanoparticle to make vaccines more powerful

    Many vaccines, including vaccines for hepatitis B and whooping cough, consist of fragments of viral or bacterial proteins. These vaccines often include other molecules called adjuvants, which help to boost the immune system’s response to the protein.Most of these adjuvants consist of aluminum salts or other molecules that provoke a nonspecific immune response. A team of MIT researchers has now sho
    March 6, 2024
    Hitchhiking cancer vaccine makes progress in the clinic

    Hitchhiking cancer vaccine makes progress in the clinic

    Therapeutic cancer vaccines are an appealing strategy for treating malignancies. In theory, when a patient is injected with peptide antigens — protein fragments from mutant proteins only expressed by tumor cells — T cells learn to recognize and attack cancer cells expressing the corresponding protein. By teaching the patient’s own immune system to attack cancer cells, these vaccines ideally would
    February 15, 2024
    Robert Langer receives Dr. Paul Janssen Award

    Robert Langer receives Dr. Paul Janssen Award

    MIT Institute Professor Robert S. Langer was recently honored with the 2023 Dr. Paul Janssen Award for his groundbreaking work in designing novel drug delivery systems that can deliver medications continuously, precisely, and at controlled rates over extended periods. Langer’s pioneering research into biomedical compounds for drug delivery and tissue engineering has impacted a wide range of medica
    February 13, 2024
    MIT’s tiny technologies go to Washington

    MIT’s tiny technologies go to Washington

    On Nov. 7, a team from the Marble Center for Cancer Nanomedicine at MIT showed a Washington audience several examples of how nanotechnologies developed at the Institute can transform the detection and treatment of cancer and other diseases.The team was one of 40 innovative groups featured at “American Possibilities: A White House Demo Day.” Technology on view spanned energy, artificial intelligenc
    December 18, 2023
    3 Questions: Darrell Irvine on making HIV vaccines more powerful

    3 Questions: Darrell Irvine on making HIV vaccines more powerful

    An MIT research team led by Professor Darrell Irvine has developed a novel kind of vaccine adjuvant: a nanoparticle that can help to stimulate the immune system to generate a stronger response to a vaccine. These nanoparticles contain saponin, a compound derived from the bark of the Chilean soapbark tree, along with a molecule called MPLA, each of which helps to activate the immune system. The adj
    December 12, 2023
    MIT engineers design more powerful RNA vaccines

    MIT engineers design more powerful RNA vaccines

    RNA vaccines against Covid-19 have proven effective at reducing the severity of disease. However, a team of researchers at MIT is working on making them even better. By tweaking the design of the vaccines, the researchers showed that they could generate Covid-19 RNA vaccines that produce a stronger immune response, at a lower dose, in mice.Adjuvants are molecules commonly used to increase the immu
    September 7, 2023
    A snapshot of cancer vaccine development

    A snapshot of cancer vaccine development

    The road to effective cancer vaccines has been long and difficult.  Although initial attempts to use a vaccine to treat cancer date back to the 1910s, the first effective therapeutic vaccine would not emerge until about a century later, when Sipuleucel-T was used to treat prostate cancer in 2010. While the FDA-approved prostate cancer vaccine generated much excitement, its success has proven diffi
    August 15, 2023
    Vaccine delivers a boost to T cell therapy

    Vaccine delivers a boost to T cell therapy

    Engineering T cells to destroy cancer cells has shown success in treating some types of cancer, such as leukemia and lymphoma. However, it hasn’t worked as well for solid tumors.One reason for this lack of success is that the T cells target only one antigen (a target protein found on the tumors); if some of the tumor cells don’t express that antigen, they can escape the T cell attack.MIT researche
    July 5, 2023
    Putting the STING into cancer immunotherapy

    Putting the STING into cancer immunotherapy

    Immune checkpoint blockade therapies have been revolutionary in the treatment of some cancer types, emerging as one of the most promising treatments for diseases such as melanoma, colon cancer, and non-small cell lung cancer.  While in some cases checkpoint blockade therapies elicit a strong immune response that clears tumors, checkpoint inhibitors do not work for all tumor types or all patients.
    May 12, 2023
    Contact
    Immunize Oregon
    PO BOX 4391, Portland, Oregon 97208

    United States

    Coordinator@immunizeor.org
    Links
    • Immunize Oregon Website
    Cookies
    Reselect cookie settings
    Community engagement platform by Hivebrite.